Results 81 to 90 of about 16,896 (199)

Finasteride for benign prostatic hyperplasia

, 1997
A randomized, double blind, placebo-controlled study (placebo and Finasteride 1 or 5 mg/die) was carried out in 34 patients with benign prostatic hyperplasia (BPH). After 12 months of treatment all patients received Finasteride 5 mg/die. Follow-up ranges
Miano, L, Manieri, C, PARADISO GALATIOTO, Giuseppe, VICENTINI, Carlo   +3 more
core  

Research Brief: Self-Reports of a Constellation of Persistent Antiandrogenic, Estrogenic, Physical, and Psychological Effects of Finasteride Usage Among Men

American Journal of Men's Health, 2018
Our research objective is to understand more, through subjective, self-reports on discussion boards/forums, persons’ experiences associated with the use of drugs that alter androgen metabolism, such as finasteride.
Alicia A. Walf, Shan Kaurejo, Cheryl A. Frye   +2 more
doaj   +1 more source

Effect of Finasteride on prostatic volume in canine prostatic hypertrophy [PDF]

, 2002
Se administró 0,1 mg/kg día de Finasteride, inhibidor selectivo de la 5 αreductasa, vía oral a caninos machos adultos con diferentes grados de hiperplasia prostática benigna. Se evaluó, mediante ecografía, el efecto de la droga sobre el tamaño prostático.
Scodellaro, Carla Floriana, Stornelli, María Alejandra, Rodríguez, Raúl Ricardo, Savignone, César A., Stornelli, María Cecilia   +4 more
core  

Effect of Finasteride on prostatic volume in canine prostatic hypertrophy [PDF]

, 2009
Se administró 0,1 mg/kg día de Finasteride, inhibidor selectivo de la 5 αreductasa, vía oral a caninos machos adultos con diferentes grados de hiperplasia prostática benigna. Se evaluó, mediante ecografía, el efecto de la droga sobre el tamaño prostático.
Scodellaro, Carla Floriana, Stornelli, María Alejandra, Rodríguez, Raúl Ricardo, Savignone, César A., Stornelli, María Cecilia   +4 more
core  

Treatment with finasteride following radical prostatectomy for prostate cancer

, 1995
The objective of this study was to evaluate the effect of finasteride (10 mg/d) or placebo on serum prostate-specific antigen (PSA) and recurrence rates in men with detectable PSA levels after radical prostatectomy. A total of 120 men, 48 to 89 years old,
Lieber, M, Andriole, G, Crawford, D, Soloway, M, Schroeder, F, DeKernion, J, Boake, R, Rajfer, J, Smith, J, Kadmon, D   +9 more
core   +1 more source

Finasteride Affects on Planaria Regeneration [PDF]

Aerospace physiology observes Cell reproduction within humans and how different substances and different environments can affect cell reproduction among all species.
Hannor, Ja\u27Hann M.
core   +1 more source

Efficacy and safety of topical finasteride spray solution in the treatment of Chinese men with androgenetic alopecia: A phase III, multicenter, randomized, double-blind, placebo-controlled study

Chinese Medical Journal
. Background:. Topical finasteride is a novel treatment for men with androgenetic alopecia (AGA). This study aimed to evaluate the efficacy and safety of topical finasteride spray solution in Chinese men with AGA. Methods:. This randomized, double-blind,
Cheng Zhou, Bin Yang, Huiming Zeng, Rushan Xia, Ningning Dang, Qinping Yang, Ji Li, Chunlei Zhang, Guoqiang Zhang, Aihua Wei, Wei Lai, Shuxia Yang, Qingchun Diao, Yangfeng Ding, Liming Wu, Lunfei Liu, Danyang Jia, Hanjie Zhu, Jianzhong Zhang, Lishao Guo   +19 more
doaj   +1 more source

The Effect of Finasteride on Parity Rates in Drosophila Melanogaster [PDF]

Finasteride has been used to treat male pattern baldness and benign prostate hyperplasia and could potentially treat female pattern baldness and polycystic ovary syndrome.
Turner, Carly, Mitchell, Carol, Bruno, Trey, Fleming, Alesha, Sandell, Dominic, Guildin, Michael   +5 more
core   +2 more sources

Finasteride in the treatment of patients with benign prostatic hyperplasia: a review

, 2009
Angela B Smith, Culley C CarsonUniversity of North Carolina Division of Urologic Surgery, Chapel Hill, NC, USAAbstract: Benign prostatic hyperplasia (BPH) is a complex and progressive disease common in aging men.
Culley C Carson, Angela B Smith
core  

Efficacy and safety of oral finasteride versus dutasteride in moderate-to-severe androgenetic alopecia in males based on trichoscopic and laboratory findings: a clinical comparison in Iran

Journal of Dermatological Treatment
Background Androgenetic alopecia (AGA) is the most common type of hair loss in men. Finasteride and dutasteride are oral 5-alpha-reductase inhibitors. This study compared their efficacy and safety in Iranian men with moderate to severe AGA.Methods This ...
Nazila Poostiyan, Zahra Nikyar, Reza Makhmali, Mohsen Hosseini, Zabihollah Shahmoradi   +4 more
doaj   +1 more source